Employee misconduct in revenue recognition; Rs 80.7 cr reversed
HIKAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 1.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Hikal Ltd disclosed employee misconduct involving alterations in revenue recognition documents. Sales would have been 2 percent lower in Q4FY25 and Q1FY26 had irregularities not occurred. Company has already reversed Rs 80.7 crore revenue for Q2FY26. Underlying sales are genuine, backed by customer purchase orders. No siphoning or fund misappropriation found. Company is evaluating reporting to authorities.
Negative short-term sentiment from revenue reversal and disclosure of internal misconduct, though management confirms no fund misappropriation.